from the good-news-i-forget-why dept.
GarryFre writes "Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein which, when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss. Already a substance has been found that shows some promise in halting the progression of the disease."
"An organization dries up if you don't challenge it with growth."
-- Mark Shepherd, former President and CEO of Texas Instruments